NVEC:NASDAQNVE Corporation Analysis
Data as of 2026-06-17 - not real-time
$101.77
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
NVE Corporation trades around $101.8, far above its DCF fair value of $29, signaling a pronounced overvaluation despite its impressive profitability – gross margin of 78%, operating margin of 62% and ROE of 25%. The stock rides a strong bullish trend, sitting above its 20‑day (≈$103) and 200‑day (≈$73) moving averages, and the 30‑day volatility is high at roughly 73% with a beta of 1.75, underscoring price sensitivity. However, the MACD histogram has turned negative and the recent price dip from $107.9 to $101.8 hints at short‑term weakness, while the support level sits near $82 and resistance near $121.
Fundamentally, the company is cash‑rich ($19.8 M) with minimal debt, no dividend payout, and modest revenue growth of 5.3%, positioning it as a growth‑oriented tech play. The sector’s cyclical nature and elevated beta elevate overall risk, but the firm’s niche spintronic technology and high operating efficiency provide a compelling long‑run narrative.
Fundamentally, the company is cash‑rich ($19.8 M) with minimal debt, no dividend payout, and modest revenue growth of 5.3%, positioning it as a growth‑oriented tech play. The sector’s cyclical nature and elevated beta elevate overall risk, but the firm’s niche spintronic technology and high operating efficiency provide a compelling long‑run narrative.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram indicating near‑term momentum weakness
- Recent price pullback toward support level
- High volatility and beta increasing short‑term risk
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustained bullish trend above key moving averages
- Strong operating margins and cash position
- Overvaluation relative to DCF but industry PE slightly lower than average
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Unique spintronic technology addressing AIoT and IIoT markets
- High ROE and low leverage providing financial resilience
- Long‑run growth potential outweighs current valuation premium
Key Metrics & Analysis
Financial Health
Revenue Growth5.30%
Profit Margin57.72%
P/E Ratio32.4
ROE25.22%
ROA15.96%
Debt/Equity1.55
P/B Ratio8.5
Op. Cash Flow$16.7M
Free Cash Flow$7.3M
Industry P/E37.0
Technical Analysis
TrendBullish
RSI51.1
Support$81.96
Resistance$121.20
MA 20$102.94
MA 50$91.22
MA 200$73.09
MACDBearish
VolumeIncreasing
Fear & Greed Index88.57
Valuation
Fair Value$29.00
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.75
Volatility72.82%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.